Document is current

Any future updates will be listed below

Correction: Rozanolixizumab in generalized myasthenia gravis: a profile of its use

Crossref DOI link: https://doi.org/10.1007/s40267-024-01115-3

Published Online: 2024-10-17

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark